Project in brief
Candida albicans is the most common coloniser of the human oral cavity. Host immunity keeps it in check as a harmless commensal but the loss of a fully competent immune system (e.g. when cancer patients receive radiotherapy or chemotherapy, or under environmental stressors such as smoking/vaping, excessive alcohol and sugar consumption) increases the likelihood of candidiasis (thrush) and mucosal ulcerations. Damage to the oral barrier triggers wound healing inflammatory responses and fungal colonization, facilitate local as well as systemic infections and may promote oral cancer progression.
There is still limited understanding of the role that C.albicans plays on oral wound healing or the etiological association between fungal infection and cancer.
This study proposes to assess would healing rate and inflammatory responses in oral cell lines stimulated with C.albicans (in vitro) as well as in saliva collected from volunteers tested for carriage of C.albicans in the oral mucosa (ex vivo). The expression of human mucosa biomarkers associated with C.albicans-driven inflammation will be explored to drive the development of antifungal functional hydrogels.